These proteins cause the walls of a person’s blood vessels to keep growing and thicken over time.
As the blood vessels narrow, the heart is forced to work harder to pump blood to the lungs.
Treatment with a combination of drugs that dilate, or relax, blood vessels can improve this outlook, but they are not a cure.
Both groups were also taking the standard medications for the condition, which help relax blood vessels to improve blood flow.
But Galiatsatos said that as promising as the drug looks, there are still many unknowns, including whether the drug will benefit all PAH patients equally.
Persons:
Katrina Barry, Barry, “, ”, Winrevair, Merck Winrevair, Vallerie McLaughlin, Panagis, Galiatsatos, isn’t, ” Barry, I’m, fanny, She’s, sotatercept, PAH, Sotatercept, “ There’s, Kristin Highland, Highland, ” Merck, Merck, Dr, Sanjay Gupta, Aaron Waxman, Barry’s, he’s, they’ve, Johnson –, Waxman, “ I’ve, “ It’s, who’ve
Organizations:
CNN, American Lung Association, US Food and Drug Administration, Merck, FDA, University of Michigan, PAH, Johns Hopkins Bayview Medical Center, New England, of Medicine, Cleveland Clinic, Institute, Clinical, CNN Health, Brigham, Women’s Hospital, Johnson
Locations:
PAH, American, Greece, Boston